跳至主要内容
临床试验/NL-OMON56721
NL-OMON56721尚未招募不适用

Characterization of intrahepatic immune responses and gene expression profiles in patients with chronic hepatitis Delta - RAPID

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Active hepatitis delta based on a positive anti-HDV and a positive HDV-RNA
  • - Patients must be >=18 years and <= 70 years.
  • - Non-cirrhotic or cirrhotic compensated liver disease
  • - Patients must be able to provie a written informed consent

排除标准

  • Clinical decompensated cirrhosis (Child-Pugh Grade B or C).
  • Hepatic imaging (ultrasound, CT or MRI) with evidence of hepatocellular
  • Females who are pregnant or breast-feeding.
  • History or other evidence of severe illness, malignancy or any other
  • condition which would make the patient, in the opinion of the investigators,
  • unsuitable for the study.
  • Received prolonged therapy with immunomodulatory agents (e.g.
  • corticosteroids) or biologics (e.g. monoclonal antibody, interferon) within 6
  • months of screening.
  • Thrombocytes < 60x109/L
  • Inability to provide written informed consent

研究者

相似试验